These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 17168789)

  • 1. Membrane interactive alpha-helices in GPCRs as a novel drug target.
    Nemoto W; Toh H
    Curr Protein Pept Sci; 2006 Dec; 7(6):561-75. PubMed ID: 17168789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GRIP: a server for predicting interfaces for GPCR oligomerization.
    Nemoto W; Fukui K; Toh H
    J Recept Signal Transduct Res; 2009 Dec; 29(6):312-7. PubMed ID: 19888901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GRIPDB - G protein coupled Receptor Interaction Partners DataBase.
    Nemoto W; Fukui K; Toh H
    J Recept Signal Transduct Res; 2011 Jun; 31(3):199-205. PubMed ID: 21410407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The study of G-protein coupled receptor oligomerization with computational modeling and bioinformatics.
    Filizola M; Weinstein H
    FEBS J; 2005 Jun; 272(12):2926-38. PubMed ID: 15955053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interface Prediction for GPCR Oligomerization Between Transmembrane Helices.
    Nemoto W; Saito A
    Methods Mol Biol; 2021; 2315():99-110. PubMed ID: 34302672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. X-ray structure breakthroughs in the GPCR transmembrane region.
    Topiol S; Sabio M
    Biochem Pharmacol; 2009 Jul; 78(1):11-20. PubMed ID: 19447219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Excitements and challenges in GPCR oligomerization: molecular insight from FRET.
    Chakraborty H; Chattopadhyay A
    ACS Chem Neurosci; 2015 Jan; 6(1):199-206. PubMed ID: 25363209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allosteric inhibition of g-protein coupled receptor oligomerization: strategies and challenges for drug development.
    Hurevich M; Talhami A; Shalev DE; Gilon C
    Curr Top Med Chem; 2014; 14(15):1842-63. PubMed ID: 25175995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Requirements and ontology for a G protein-coupled receptor oligomerization knowledge base.
    Skrabanek L; Murcia M; Bouvier M; Devi L; George SR; Lohse MJ; Milligan G; Neubig R; Palczewski K; Parmentier M; Pin JP; Vriend G; Javitch JA; Campagne F; Filizola M
    BMC Bioinformatics; 2007 May; 8():177. PubMed ID: 17537266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of interfaces for oligomerizations of G-protein coupled receptors.
    Nemoto W; Toh H
    Proteins; 2005 Feb; 58(3):644-60. PubMed ID: 15593372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Homo- and hetero-oligomerization of G protein-coupled receptors.
    Lee SP; O'Dowd BF; George SR
    Life Sci; 2003 Dec; 74(2-3):173-80. PubMed ID: 14607244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update of the GRIP web service.
    Saito A; Tsuchiya D; Sato S; Okamoto A; Murakami Y; Mizuguchi K; Toh H; Nemoto W
    J Recept Signal Transduct Res; 2020 Aug; 40(4):348-356. PubMed ID: 32148150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computational methods in drug design: modeling G protein-coupled receptor monomers, dimers, and oligomers.
    Reggio PH
    AAPS J; 2006 May; 8(2):E322-36. PubMed ID: 16796383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of GPCR dimerisation/oligomerisation in receptor signalling.
    Milligan G; Canals M; Pediani JD; Ellis J; Lopez-Gimenez JF
    Ernst Schering Found Symp Proc; 2006; (2):145-61. PubMed ID: 17703581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. G-protein-coupled receptor heterodimerization: assay technologies to clinical significance.
    Kent T; McAlpine C; Sabetnia S; Presland J
    Curr Opin Drug Discov Devel; 2007 Sep; 10(5):580-9. PubMed ID: 17786857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oligomerization of GPCRs involved in endocrine regulation.
    Kleinau G; Müller A; Biebermann H
    J Mol Endocrinol; 2016 Jul; 57(1):R59-80. PubMed ID: 27151573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GPCR homo-oligomerization.
    Milligan G; Ward RJ; Marsango S
    Curr Opin Cell Biol; 2019 Apr; 57():40-47. PubMed ID: 30453145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The structure and dynamics of GPCR oligomers: a new focus in models of cell-signaling mechanisms and drug design.
    Filizola M; Weinstein H
    Curr Opin Drug Discov Devel; 2005 Sep; 8(5):577-84. PubMed ID: 16159019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of G-protein-coupled receptor hetero-oligomerization on function and pharmacology.
    Maggio R; Novi F; Scarselli M; Corsini GU
    FEBS J; 2005 Jun; 272(12):2939-46. PubMed ID: 15955054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Dynamics of GPCR Oligomerization and Their Functional Consequences.
    Sleno R; Hébert TE
    Int Rev Cell Mol Biol; 2018; 338():141-171. PubMed ID: 29699691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.